Zobrazeno 1 - 10
of 11
pro vyhledávání: '"ELIZABETH D. MOYER"'
Autor:
Elizabeth D. Moyer, Michael C. Powanda
Publikováno v:
Inflammopharmacology
There is an array of plasma protein alterations that occur in a wide variety of species, including humans in response to trauma, inflammation and infections, seemingly irrespective of etiologic agent. In numerous species, these plasma proteins are pa
Autor:
Elizabeth D Moyer, Gary D. Novack
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 34:237-238
Autor:
Gary D. Novack, Elizabeth D Moyer
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 32(1)
Planning the nonclinical development program for an ophthalmic product requires first an understanding of how the drug will be used in the clinic-topical, injected, relatively short duration of testing, chronic testing, and what is already known abou
Autor:
Elizabeth D Moyer, Gary D. Novack
Publikováno v:
The ocular surface. 11(2)
Autor:
DAVID APPELGATE, ALEXANDRA J. BARAN, RON COHEN, MARK D. DIBNER, PETER DRAKE, SUE GOETINCK AMBROSE, MARY ANN GRAY, GENEVIEVE HADDAD, CAROL HALL, PHILIP W. HAMMER, BENTE HANSEN, GINA LENTO, ROGER LONGMAN, ERIN HALL MEADE, ELIZABETH D. MOYER, DEEPA PAKIANATHAN, RONALD PEPIN, CLAYTON R. RANDALL, CYNTHIA ROBBINS-ROTH, ROBERT ROTH, TONY RUSSO, GAIL SCHECHTER, PAULA SZOKA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c032521811005423a937a0f34216fd47
https://doi.org/10.1016/b978-012589376-3/50027-9
https://doi.org/10.1016/b978-012589376-3/50027-9
Autor:
Elizabeth D. Moyer
Publisher Summary This chapter focuses most specifically on regulatory affairs as they apply to the pharmaceutical industry. Current science training does not direct students toward nontraditional career paths. Regulatory affairs present a reasonable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ae63d3258a439b214d56b0c571e0a8c
https://doi.org/10.1016/b978-012589376-3/50040-1
https://doi.org/10.1016/b978-012589376-3/50040-1
Autor:
Michael C. Powanda, Elizabeth D. Moyer
Publikováno v:
Inflammopharmacology. 12(3)
Publikováno v:
The Journal of biological chemistry. 266(31)
Site-specific mutagenesis techniques have been used to construct active site variants of the Kunitz-type protease inhibitor domain present in the Alzheimer's beta-amyloid precursor protein (APP-KD). Striking alteration of its protease inhibitory prop
Autor:
Michael C. Powanda, Elizabeth D. Moyer
Publikováno v:
Inflammation and Drug Therapy Series ISBN: 9789401070560
Like all historical events, the stages of development of our knowledge and understanding of the family of proteins presently called interleukin-1 (IL-1) can be assigned conveniently to one of three phases: past, present and future. We suggest, howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::861b8df0608272000de9a8d7934da705
https://doi.org/10.1007/978-94-009-1253-3_10
https://doi.org/10.1007/978-94-009-1253-3_10
Autor:
Michael C. Powanda, Elizabeth D. Moyer
Publikováno v:
Physiology ISBN: 9781468445763
For the purposes of this discussion, the reticuloendothelial or mononuclear phagocyte system will be considered to include monocytes, histiocytes, Kupffer cells, alveolar macrophages, and phagocytic cells in spleen, lymph nodes, bone marrow, the nerv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72c41ded714f5a5deeb6509ec607be6f
https://doi.org/10.1007/978-1-4684-4574-9_14
https://doi.org/10.1007/978-1-4684-4574-9_14